HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrew W Gardner Selected Research

Intermittent Claudication

3/2016Sedentary behavior is associated with impaired biomarkers in claudicants.
6/2013Apolipoprotein profiles in subjects with and without peripheral artery disease.
1/2013Influence of peripheral artery disease and statin therapy on apolipoprotein profiles.
11/2010Gender differences in daily ambulatory activity patterns in patients with intermittent claudication.
10/2010Reduced high-density lipoprotein level is linked to worse ankle brachial index and peak oxygen uptake in postmenopausal women with peripheral arterial disease.
3/2010Walking economy before and after the onset of claudication pain in patients with peripheral arterial disease.
7/2009Sex differences in calf muscle hemoglobin oxygen saturation in patients with intermittent claudication.
7/2009Resting energy expenditure in subjects with and without intermittent claudication.
11/2008Management of lower extremity peripheral arterial disease.
10/2008The effect of hypercholestrolemia on calf muscle hemoglobin oxygen saturation in patients with intermittent claudication.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrew W Gardner Research Topics

Disease

31Peripheral Arterial Disease
01/2022 - 05/2002
18Intermittent Claudication
03/2016 - 05/2002
11Inflammation (Inflammations)
10/2020 - 09/2014
8Pain (Aches)
10/2019 - 03/2004
4Hypertension (High Blood Pressure)
10/2020 - 11/2008
3Ischemia
07/2013 - 06/2006
3Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2011 - 06/2006
2Dyslipidemias (Dyslipidemia)
10/2020 - 05/2018
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
08/2012 - 09/2009
2Overweight
05/2011 - 03/2007
2Abdominal Obesity
03/2010 - 06/2008
2Hypercholesterolemia
11/2008 - 10/2008
2Hyperemia
06/2008 - 06/2006
1Cognitive Dysfunction
10/2021
1Coronary Artery Disease (Coronary Atherosclerosis)
05/2018
1Chronic Renal Insufficiency
05/2018
1Atherosclerosis
10/2016
1Fibrosis (Cirrhosis)
10/2016
1Stroke (Strokes)
06/2016
1Insulin Resistance
03/2016
1Myocardial Infarction
01/2013
1Cardiovascular Diseases (Cardiovascular Disease)
08/2012
1Hypoglycemia (Reactive Hypoglycemia)
09/2009
1Diabetes Complications
09/2009
1Vascular Diseases (Vascular Disease)
01/2009
1Chronic Limb-Threatening Ischemia
11/2008
1Body Weight (Weight, Body)
12/2006

Drug/Important Bio-Agent (IBA)

11Hemoglobins (Hemoglobin)IBA
01/2020 - 08/2007
10Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2015
7AntioxidantsIBA
10/2019 - 05/2015
6Oxygen (Dioxygen)IBA
11/2013 - 06/2006
4Pain-FreeIBA
05/2018 - 02/2010
3Glucose (Dextrose)FDA LinkGeneric
01/2019 - 06/2008
2Blood Glucose (Blood Sugar)IBA
10/2019 - 01/2019
2Reactive Oxygen Species (Oxygen Radicals)IBA
06/2016 - 05/2015
2LipidsIBA
03/2016 - 10/2010
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2013 - 01/2013
2ApolipoproteinsIBA
06/2013 - 01/2013
1SugarsIBA
10/2020
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
10/2020
1Folic Acid (Vitamin M)FDA LinkGeneric
10/2020
1Hydroxyl RadicalIBA
05/2018
1Galectin 3 (LGALS3)IBA
10/2016
1C-Reactive ProteinIBA
06/2016
1Cell Adhesion Molecule-1IBA
06/2016
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
06/2016
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2014
1LDL CholesterolIBA
01/2013
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
08/2012
1Apolipoprotein C-IIIIBA
05/2011
1CholesterolIBA
04/2011
1HDL CholesterolIBA
10/2010
1HDL LipoproteinsIBA
10/2010
1Insulin (Novolin)FDA Link
09/2009
1P 500IBA
07/2009
1Vasodilator Agents (Vasodilators)IBA
11/2008
1Clopidogrel (Plavix)FDA Link
11/2008
1Cilostazol (Pletal)FDA LinkGeneric
11/2008
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2008
1N 30IBA
03/2007
1MercuryIBA
12/2006
1Plasminogen InactivatorsIBA
07/2002
1Tissue Plasminogen Activator (Alteplase)FDA Link
07/2002

Therapy/Procedure

10Exercise Therapy (Therapy, Exercise)
10/2019 - 05/2002
7Therapeutics
10/2021 - 03/2004
2Resistance Training
10/2019 - 09/2014
1Diet Therapy (Therapy, Diet)
08/2012
1Glycemic Control
09/2009